Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Fluorescent β2 antagonist [(±)-propranolol] (AC122)
Cat.#: ASSD-122
Specifications
Description Fluorescent adrenoceptor β2 antagonist (apparent KD values are 8.87, 7.25 and 6.98 for β2, β1 and β3 respectively). Antagonizes the activity of isoprenaline, a non-selective β-adrenoceptor agonist. Synonyms β2 -633-AN Size 500 μg Applications For imaging at β1 / β2 / β3 adrenoceptors use solutions up to 100 nM. Molecule Weight 834 Purity >97% Solubility Soluble in DMSO Excitation 633 nm Emission 650 nm Storage Store at -20° C Shipping Shipped at 4°C Important We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-175 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) 25 mg inquiry ASSD-155 Bromophenol blue (AC155) 5g inquiry ASSD-115 7-Amino-4-methylcoumarin (AC115) 100 mg, 500 mg, 1 g inquiry ASSD-193 N-(Aminoethyl)-5-naphthylamine-1-sulfonic Acid (AC193) 1 g inquiry ASSD-202 5(6)-Carboxytetramethylrhodamine (AC202) 100 mg, 250 mg inquiry ASSD-170 BAPTA-AM (AC170) 25 mg inquiry ASSD-199 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) 500 μg inquiry ASSD-147 Rhodamine phalloidin-TRITC (AC147) 300 tests, 100μg inquiry ASSD-195 6-Aminofluorescein (AC195) 1 g inquiry ASSD-212 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) 25 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket